Gene Test Guides Eczema Care
Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis
-
1
A 487-gene expression profile test identifies atopic dermatitis patients likely to respond to JAK inhibitors over Th2-targeted biologics.
-
2
The study developed a gene expression profile test using noninvasive skin scrapings to classify patients into two molecular subgroups.
-
3
Patients with a JAK inhibitor–responder profile showed better disease clearance and symptom control with JAK inhibitors than Th2 therapies.
-
4
The test employs a simple skin sampling method and standard RNA sequencing, positioning it as a potential companion diagnostic.
-
5
Molecular stratification may streamline care by aligning therapy selection with individual patient profiles, enhancing treatment outcomes.